Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gut Microbiota in Patients With Haematological Malignancies Undergoing CAR-T Cell Therapy: A Randomized Phase II Trial Comparing Standard of Care Versus a Restrictive Antibiotic Strategy

NCT07842198 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.

NCT NCT07842198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07842198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gut Microbiota in Patients With Haematological Malignancies Undergoing CAR-T Cell Therapy: A Randomized Phase II Trial Comparing Standard of Care Versus a Restrictive Antibiotic Strategy
Lead sponsor
Zealand University Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 1, 2027
Completion date
December 31, 2031
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gut microbiota, large b-cell lymphoma (lbcl), multiple myeloma (mm)